From its inception Pall Corporation has been committed to providing customers with innovative solutions that protect their precious fluids and prolong the life of expensive equipment.
Pall now spends more than $80 million dollars in R&D annually and our R&D efforts continue to be the engine that propels our success. Our technological advancements help customers across the globe purify oils and gases, filter contaminates from water, protect the integrity of microelectronics and accelerate the discovery, development and scale-up of biotech drugs.
Pall’s commitment to technology leadership is evidenced by our state-of-the-art manufacturing processes, ground-breaking product offerings, unique SLS global technical support group, and our enviable patent portfolio. The Pall companies have developed over 1,100 U.S.patents since our founder Dr. David B. Pall’s first application in 1945.
In accordance with Section 287(a) of Title 35 of the United States Code, the reader is hereby placed on notice of Pall Corporation’s rights in the United States Patents listed on this site and associated with the following products.
Looking for Life Sciences?
The Biotechnology, Laboratory and Medical businesses of Pall Corporation became part of Cytiva on May 1st. All content associated with these business units can be found on Cytiva.com.